These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 4152974)

  • 1. Nomifensine: a new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatum.
    Hunt P; Kannengiesser M; Raynaud J
    J Pharm Pharmacol; 1974 May; 26(5):370-1. PubMed ID: 4152974
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative effects of benztropine and nomifensine on dopamine uptake and release from striatal synaptosomes.
    McKillop D; Bradford HF
    Biochem Pharmacol; 1981 Oct; 30(20):2753-8. PubMed ID: 7317073
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo effects of benztropine and nomifensine on dopamine and noradrenaline terminals in rat brain.
    Broch OJ
    Eur J Pharmacol; 1979 Oct; 58(4):419-24. PubMed ID: 510376
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of phencyclidine, amphetamine and related compounds on dopamine release from and uptake into striatal synaptosomes.
    Bowyer JF; Spuhler KP; Weiner N
    J Pharmacol Exp Ther; 1984 Jun; 229(3):671-80. PubMed ID: 6726652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nomifensine on motor activity, dopamine turnover rate and cyclic 3',5;-adenosine monophosphate concentrations of rat striatum.
    Gerhards HJ; Carenzi A; Costa E
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 286(1):49-63. PubMed ID: 4375258
    [No Abstract]   [Full Text] [Related]  

  • 6. The accumulation of dopamine into striatal synaptosomes, and its inhibition: comparison of crude, partially purified and purified synaptosomal preparations.
    Tuomisto J; Tuomisto L
    Med Biol; 1979 Aug; 57(4):238-45. PubMed ID: 513880
    [No Abstract]   [Full Text] [Related]  

  • 7. Dopamine uptake in striatal and hypothalamic synaptosomes: conformational selectivity of the inhibition.
    Tuomisto L; Tuomisto J; Smissman EE
    Eur J Pharmacol; 1974 Mar; 25(3):351-61. PubMed ID: 4827861
    [No Abstract]   [Full Text] [Related]  

  • 8. Methylphenidate-like effects of the new antidepressant drug nomifensine (HOE 984).
    Braestrup C; Scheel-Krüger J
    Eur J Pharmacol; 1976 Aug; 38(2):305-12. PubMed ID: 986308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of nomifensine (HOE 984), a new antidepressant, on uptake of noradrenaline and serotonin and on release of noradrenaline in rat brain synaptosomes.
    Schacht U; Heptner W
    Biochem Pharmacol; 1974 Dec; 23(24):3413-22. PubMed ID: 4441422
    [No Abstract]   [Full Text] [Related]  

  • 10. Dopamine in the mesolimbic system of the rat brain: endogenous levels and the effects of drugs on the uptake mechanism and stimulation of adenylate cyclase activity.
    Horn AS; Cuello AC; Miller RJ
    J Neurochem; 1974 Feb; 22(2):265-70. PubMed ID: 4829953
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine.
    Raiteri M; Cerrito F; Cervoni AM; Levi G
    J Pharmacol Exp Ther; 1979 Feb; 208(2):195-202. PubMed ID: 216794
    [No Abstract]   [Full Text] [Related]  

  • 12. Simultaneous evaluation by a double labelling method of drug-induced uptake inhibition and release of dopamine in synaptosomal preparation of rat striatum.
    Bonnet JJ; Lemasson MH; Costentin J
    Biochem Pharmacol; 1984 Jul; 33(13):2129-35. PubMed ID: 6743357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similar potency ratios of amphetamine optical isomers for inhibition of dopamine uptake by synaptosomes of corpus striatum, olfactory tubercle and prefrontal cortex of the rat.
    Matthews RT; Shore PA
    Biochem Pharmacol; 1984 Sep; 33(17):2817-9. PubMed ID: 6466390
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of the capacities of isomers of amphetamine, deoxypipradrol and methylphenidate to inhibit the uptake of tritiated catecholamines into rat cerebral cortex slices, synaptosomal preparations of rat cerebral cortex, hypothalamus and striatum and into adrenergic nerves of rabbit aorta.
    Ferris RM; Tang FL; Maxwell RA
    J Pharmacol Exp Ther; 1972 Jun; 181(3):407-16. PubMed ID: 5033010
    [No Abstract]   [Full Text] [Related]  

  • 15. Extracellular dopamine in rat striatum following uptake inhibition by cocaine, nomifensine and benztropine.
    Church WH; Justice JB; Byrd LD
    Eur J Pharmacol; 1987 Jul; 139(3):345-8. PubMed ID: 3666010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the uptake of 3-H-dopamine and 14-C-5-hydroxytryptamine in mouse striatum slices.
    Ross SB; Rényi AL
    Acta Pharmacol Toxicol (Copenh); 1975 Jan; 36(1):56-66. PubMed ID: 1173723
    [No Abstract]   [Full Text] [Related]  

  • 17. Release of biogenic amines from isolated nerve endings.
    Raiteri M; Bertollini A; del Carmine R; Levi G
    Adv Exp Med Biol; 1976; 69():319-35. PubMed ID: 941741
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of various isoquinoline alkaloids on in vitro 3H-dopamine uptake by rat striatal synaptosomes.
    Protais P; Arbaoui J; Bakkali EH; Bermejo A; Cortes D
    J Nat Prod; 1995 Oct; 58(10):1475-84. PubMed ID: 8676127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine and norepinephrine uptake by rat brain synaptosomes: relative inhibitory potencies of 1- and d-amphetamine and amantadine.
    Thornburg JE; Moore KE
    Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):81-9. PubMed ID: 4686111
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of in vivo and in vitro amphetamine on the synaptosomal uptake of dopamine in mouse striatum.
    Hadfield MG
    Res Commun Chem Pathol Pharmacol; 1985 May; 48(2):183-8. PubMed ID: 4023407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.